Mulay James - Insider Non-Derivative Transactions at CG Oncology, Inc. (CGON) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 9, 2025, Mulay James's relationship to CG Oncology, Inc. (CGON) is Director, and currently has 5,903 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CGON insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Mulay James - Insider Non-Derivative Transactions of CGON Common Stock

Mulay James - Insider Non-Derivative Transactions at CGON

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 10, 2025	Sell -- (Common Stock)	5903	43.99	0
Oct 10, 2025	M -- (Common Stock)	5903	3.72	5903
Sep 30, 2025	Sell -- (Common Stock)	12755	39.19	0
Sep 30, 2025	M -- (Common Stock)	12755	1.82	12755
Sep 20, 2025	Sell -- (Common Stock)	3574	38.99	0
Sep 20, 2025	M -- (Common Stock)	3574	1.82	3574
Sep 19, 2025	Sell -- (Common Stock)	19112	39.01	0
Sep 19, 2025	M -- (Common Stock)	19112	1.82	19112
Sep 6, 2025	Sell -- (Common Stock)	3113	33.22	0
Sep 6, 2025	Sell -- (Common Stock)	7465	32.64	3113
Sep 6, 2025	Sell -- (Common Stock)	4095	31.42	10578
Sep 6, 2025	Sell -- (Common Stock)	12342	30.47	14673
Sep 6, 2025	M -- (Common Stock)	27015	0.6	27015